Advanced BioMedical Technologies, Inc. (ABMT)
OTCMKTS · Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
May 16, 2025, 4:00 PM EDT

ABMT Statistics

Total Valuation

ABMT has a market cap or net worth of 28,362.

Market Cap 28,362
Enterprise Value n/a

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

ABMT has 70.90 million shares outstanding.

Current Share Class 70.90M
Shares Outstanding 70.90M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.26
PB Ratio -0.00
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio 3.11
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.03

Current Ratio 0.03
Quick Ratio 0.01
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -146.78
Interest Coverage -1.35

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -78.11%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 5.18%
Revenue Per Employee 6,461
Profits Per Employee -44,305
Employee Count 17
Asset Turnover 0.32
Inventory Turnover 0.21

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -33.33% in the last 52 weeks. The beta is 1.87, so ABMT's price volatility has been higher than the market average.

Beta (5Y) 1.87
52-Week Price Change -33.33%
50-Day Moving Average 0.00
200-Day Moving Average 0.00
Relative Strength Index (RSI) 41.25
Average Volume (20 Days) 208

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.07

Income Statement

In the last 12 months, ABMT had revenue of 109,844 and -753,180 in losses. Loss per share was -0.01.

Revenue 109,844
Gross Profit 81,641
Operating Income -423,768
Pretax Income -753,180
Net Income -753,180
EBITDA -408,872
EBIT -423,768
Loss Per Share -0.01
Full Income Statement

Balance Sheet

The company has 6,983 in cash and 6.36 million in debt, giving a net cash position of -6.35 million or -0.09 per share.

Cash & Cash Equivalents 6,983
Total Debt 6.36M
Net Cash -6.35M
Net Cash Per Share -0.09
Equity (Book Value) -8.18M
Book Value Per Share -0.12
Working Capital -8.34M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9,134 and capital expenditures -52,463, giving a free cash flow of -43,329.

Operating Cash Flow 9,134
Capital Expenditures -52,463
Free Cash Flow -43,329
FCF Per Share -0.00
Full Cash Flow Statement

Margins

Gross Margin 74.32%
Operating Margin -385.79%
Pretax Margin -685.68%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ABMT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.45%
Shareholder Yield -0.45%
Earnings Yield -2,655.60%
FCF Yield -152.77%

Stock Splits

The last stock split was on March 13, 2009. It was a forward split with a ratio of 10.

Last Split Date Mar 13, 2009
Split Type Forward
Split Ratio 10

Scores

ABMT has an Altman Z-Score of -65.92. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -65.92
Piotroski F-Score n/a